Report of PDA Closur by Nonsurgical Approach in Pediatric Less than 15 Years Old in Emam Khomeini Hospital Ahvaz

Document Type : Original Article

Authors

1 Department of Pediatric Cardiology, Cardiovascular Diseases, Atherosclosis Cardiovascular Research Center (ACRC).Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran.

2 Department of Pediatric, Ahvaz Jundishpur, University of Medical Sciences, Ahvaz, Iran. 3 -Department of Pediatric Neurology. Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran.

3 Department of Pediatric Neurology. Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran.

4 Department of Pediatric, Ahvaz Jundishpur, University of Medical Sciences, Ahvaz, Iran.

5 Medical student, Golestan Hospital , Ahvaz Jundishpur University of Medical Sciences, Ahvaz, Iran.

Abstract

Background and Objective: Ductus arterisus is a large normally duct that communicate pulmonary artery and disending aorta in fetus. After birth and respiration this duct is normally closed. One of the congenital heart diseases is patent ductus arteriosus (PDA). Patency of this duct results in heart failure or endarteritis. Treatment involves both surgical and non-surgical interventions. In this study we evaluate our first non-surgical intervention experiences in Khuzestan.
Subjects and Methods: Fourteen PDA patients who were diagnosed by echocardiography underwent of transcatheter closure with amplatzer or coil
Results: Narrowest part of the PDA close to pulmonary artery had a median size of 3.7 mm (range from 1.6- 6.2 mm). All PDA patents with exception of one, complete occlusion was acheived after the procedure. On follow up, that patient had no residual shunt after three months. None of our patients had complications immediately and on follow-up.
Conclusion: Our fist experience showed that PDA occluder by amplatzer or coil is safe and effective and recommended for majority of PDA.

Keywords

References

-Moore P, Michael M. Brook MD, Michael A, Heymann MD. Patent Ductus Arteriosus and Aortopulmonary Window. In: Moss AJ, Allen HD, Driscoll DJ, Shaddy RE, Feltes TF. Moss and Adams' heart disease in infants, children, and adolescents: including the fetus and young adults. 7th ed. Philadelphia: Wolters Klumer/Lippincott Williams & Wilkins; 2008. p.683-702.
2-Alzamora-Castro V, Battilana G, Abugattas R, Sialer S. Patent ductus arteriosus and high altitude. Am J Cardiol 1960;5:761–3.
3-Rudolph AM, Drorbaugh JE, Auld PA, Rudolph AJ, Nadas AS, Smith CA, et al. Studies on the circulation in the neonatal period. The circulation in the respiratory distress syndrome. Pediatrics 1961;27:551–66.
4-Danilowicz D, Rudolph AM, Hoffman JI. Delayed closure of the ductus arteriosus in premature infants. Pediatrics 1966;37(1):74–8.
5-Siassi B, Emmanouilides GC, Cleveland RJ, Hirose F. Patent ductus arteriosus complicating prolonged assisted ventilation in respiratory distress syndrome. J Pediatr 1969;74(1):11–9.
6-Kitterman JA, Edmunds LH Jr, Gregory GA, Heymann MA, Tooley WH, Rudolph AM. Patent ducts arteriosus in premature infants. Incidence, relation to pulmonary disease, and management. N Engl J Med 1972;287(10):473–7.
7-Clyman RI, Jobe A, Heymann MA, Ikegami M, Roman C, Payne B, et al. Increased shunt through the patent ductus arteriosus after surfactant replacement therapy. J Pediatr 1982;100(1):101–7.
8-Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med 1976;295(10):530–3.
9-Mahony L, Carnero V, Brett C, Heymann MA, Clyman RI. Prophylactic indomethacin therapy for patent ductus arteriosus in very-low-birth-weight infants. N Engl J Med 1982;306(9):506–10.
10-Keller RL, Tacy TA, Fields S, Ofenstein JP, Aranda JV, Clyman RI. Combined treatment with a nonselective nitric oxide synthase inhibitor (I-NMMA) and indomethacin increases ductus constriction in extremely premature newborns. Pediatr Res 2005;58(6):1216–21.
11-Thomas RL, Parker GC, Van Overmeire B, Aranda JV. A meta-analysis of ibuprofen versus indomethacin for closure of patent ductus arteriosus. Eur J Pediatr 2005;164(3):135–40.
12-Aranda JV, Thomas R. Systematic review: intravenous Ibuprofen in preterm newborns. Semin Perinatol 2006;30(3):114–20.
13-Mitchell SC, Korones SB, Berendes HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation 1971;43(3):323–32.
14-Patel HT, Cao QL, Rhodes J, Hijazi ZM. Long-term outcome of transcatheter coil closure of small to large patent ductus arteriosus. Catheter Cardiovasc Interv 1999;47(4):457–61.
15-Alwi M, Kang LM, Samion H, Latiff HA, Kandavel G, Zambahari R. Transcatheter occlusion of native persistent ductus arteriosus using conventional Gianturco coils. Am J Cardiol 1997;79(10):1430–2.
16-Masura J, Tittel P, Gavora P, Podnar T. Long-term outcome of transcatheter patent ductus arteriosus closure using Amplatzer duct occluders. Am Heart J 2006;151(3):755.e7–10.
17-Masura J, Walsh KP, Thanopoulous B, Chan C, Bass J, Goussous Y, et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol 1998;31(4):878–82.
18-Hazama S, Sakamoto I, Yamachika S, Ariyoshi T, Takai H, Eishi K. Endovascular surgery using an original occluder for patent ductus arteriosus in an adult patient. Jpn J Thorac Cardiovasc Surg 2005;53(1):58-61.
19- Azhar AS, Abd El-Azim AA, Habib HS. Transcatheter closure of patent ductus arteriosus: Evaluating the effect of the learning curve on the outcome. Ann Pediatr Cardiol 2009;2(1):36-40.
20-Al-Motarreb A, Al-Hammadi M, Shamsan M, Kherbash H, Al-Hakeem F. Percutaneous transcatheter closure of patent ductus arteriosus using amplatzer duct occluder: First yemeni experience.  J Gulf Heart Assoc 2006;7(3):101-4.
21-Wiyono SA, Witsenburg M, de Jaegere PP, Roos-Hesselink JW. Patent ductus arteriosus in adults: Case report and review illustrating the spectrum of the disease. Neth Heart J 2008;16(7-8):255–9.
22-Vázquez-Antona CA, Vallejo M, Becerra RB, González A, Hernández AB, Barrón JV. [Treatment of patent ductus arteriosus. Comparison of costs between surgical and trans-catheter closures in a public institution]. Arch Cardiol Mex 2004;74(4):276-82. [In Spanish]
23-Jan SL, Hwang B, Fu YC, Chi CS. Transcatheter closure of a large patent ductus arteriosus in a young child using the Amplatzer duct occluder. Pediatr Cardiol 2005;26(5):703-6.
24-Pass RH, Hijazi Z, Hsu DT, Lewis V, Hellenbrand WE. Multicenter USA Amplatzer patent ductus arteriosus occlusion device trial: initial and one-year results. J AM Coll Cardiol 2004:44(3):513-9.
Jundishapur Scientific Medical Journal
Volume 12, Issue 4 - Serial Number 85
July and August 2013
Pages 439-446

Files

History

  • Receive Date: 05 February 2012
  • Revise Date: 26 January 2013
  • Accept Date: 11 February 2013

Share

How to cite

Statistics